A virtual meeting place for individuals and organizations dedicated to reducing the social, health and economic harms associated with drugs and drug policies.

A not-for-profit professional organization devoted to promoting multidisciplinary research and education in spirituality, culture, healing, and health care.

The Eurasian Harm Reduction Network (EHRN) is a regional network with a mission to support, develop, and advocate for harm reduction approaches in the field of drugs, HIV/AIDS, public health, and social exclusion by following the principles of humanism, tolerance, partnership, and respect for human rights and freedoms.

The Open Society Institute Global Drug Policy Program aims to broaden, diversify, and consolidate the network of like-minded organizations that are actively challenging the current state of international drug policy.

Since its inception in 1994 the Hungarian Civil Liberties Union (HCLU) has been a leading NGO in the field of drug policy reform advocacy in Hungary.  Patterned after the successful model of the American Civil Liberties Union, HCLU provides legal aid service for vulnerable populations, such as drug users, psychiatric patients and people living with HIV/AIDS in addition to its drug policy reform activities.

ICAAT's mission is to promote among medical professionals the humane treatment of people who are living with opioid addiction by making available to healthcare providers relevant medical, legal and policy information and by advocating for change in attitudes that constrain optimal treatment delivery.

The International Drug Policy Consortium is a global network of national and international NGOs that specialise in issues related to illegal and legal drug use. We have come together to pool our knowledge and contacts to advocate for more humane and effective drug policies at national and international level.

IHRA is the leading organisation in promoting evidence based harm reduction policies and practices on a global basis for all psychoactive substances (including illicit drugs, tobacco and alcohol).

The International Harm Reduction Development Program, part of OSI's Public Health Program, focuses on diminishing the individual and social harms associated with drug use—particularly the risk of HIV infection—through innovative measures based on the philosophy of harm reduction.

The Latin American Commission on Drugs and Democracy is an initiative born of ex-presidents Cesar Gaviria, from Colombia; Ernesto Zedillo, from Mexico and Fernando Henrique Cardoso, from Brazil. Eighteen eminent members from different countries in the region compose the Commission. Its objective is to evaluate the effectiveness and impact of current drug policy and to contribute towards more efficient, safe and humane policies.

A membership-based, IRS-approved 501 (c) (3) non-profit research and educational organization. MAPS' mission is to develop psychedelics and marijuana into legal prescription medicines for therapeutic applications. MAPS is also engaged in efforts to educate people about the benefits and risks of psychedelics and medical marijuana.

Lebanese Addiction Center in Beirut, advocates for the prevention of drug dependency and other addictions, and will initiate innovative treatment and services for a better-adapted healthcare system for drug users in Lebanon. Fully embraces a harm reduction approach.

TalkingDrugs is an online space reflecting the global challenge posed by illicit drugs. It provides an opportunity to share stories and insights that will help us find better ways to control illicit drugs and prevent them causing excessive harm.

A campaigning coalition of drug users, health and social care workers, criminal justice workers and educationalists that aims to put public health and human rights at the centre of drug treatment and service provision for drug users.

TNI's Drugs programme has been analysing since 1996 the trends in the illegal drugs market and in drug policies globally. The programme has been working for a reassessment of the conventional repressive drug policy approaches, and in favour of pragmatic policies based on harm reduction principles for consumers as well as small producers.

Methadone and buprenorphine, also known as medication-assisted treatment, are the best researched and most effective treatments for opiate dependence. By eliminating withdrawal and reducing cravings, methadone and buprenorphine allow opiate users to reduce or stop injection, which helps prevent HIV.